Ocular Therapeutix (OCUL) EBITDA Margin (QoQ) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Ocular Therapeutix 1.99 Bn 1.99 Bn 9.46 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -33,897.00
Dec 31, 2025 -5,414.00
Sep 30, 2025 3,022.00
Jun 30, 2025 9,490.00
Mar 31, 2025 -30,139.00
Dec 31, 2024 213.00
Sep 30, 2024 -3,307.00
Jun 30, 2024 -5,113.00
Mar 31, 2024 -7,854.00
Dec 31, 2023 -806.00
Sep 30, 2023 805.00
Jun 30, 2023 3,315.00
Mar 31, 2023 -3,105.00
Dec 31, 2022 4,250.00
Sep 30, 2022 -1,769.00
Jun 30, 2022 -2,714.00
Mar 31, 2022 1,141.00
Dec 31, 2021 1,405.00
Sep 30, 2021 1,196.00
Jun 30, 2021 10,286.00
Mar 31, 2021 -8,034.00
Dec 31, 2020 4,319.00
Sep 30, 2020 90,147.00
Jun 30, 2020 -50,304.00
Mar 31, 2020 31,183.00
Dec 31, 2019 184,317.00
Sep 30, 2019 53,113.00
Jun 30, 2019 67,261.00
Mar 31, 2019 -54,335.00
Dec 31, 2018 -43,813.00
Sep 30, 2018 -88,381.00
Jun 30, 2018 191,828.00
Mar 31, 2018 -135,818.00
Dec 31, 2017 28,613.00
Sep 30, 2017 128,950.00
Jun 30, 2017 -89,188.00
Mar 31, 2017 -86,295.00
Dec 31, 2016 -49,837.00
Sep 30, 2016 58,018.00
Jun 30, 2016 -355.00
Mar 31, 2016 12,352.00
Dec 31, 2015 2.54 Mn
Sep 30, 2015 -2.59 Mn
Jun 30, 2015 100,168.00
Mar 31, 2015 -160,898.00
Dec 31, 2014 352,565.00
Sep 30, 2014 148,899.00
Jun 30, 2014 1.87 Mn